0 Votes

Changes for page Research at a Glance

Last modified by Ryan C on 2025/06/26 03:09

From version 70.1
edited by Ryan C
on 2025/03/16 03:56
Change comment: There is no comment for this version
To version 72.1
edited by Ryan C
on 2025/03/16 05:13
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -1203,77 +1203,329 @@
1203 1203  
1204 1204  {{html}}<hr style="border: 3px solid red;">{{/html}}
1205 1205  
1206 -{{expand title="Study: Genetic Analysis of African Populations: Human Evolution and Complex Disease" expanded="false"}}
1207 -**Source:** *Nature Reviews Genetics*
1206 +
1207 +
1208 +{{expand title="Study: Racial Bias in Pain Assessment and Treatment Recommendations" expanded="false"}}
1209 +**Source:** *Proceedings of the National Academy of Sciences (PNAS)*
1210 +**Date of Publication:** *2016*
1211 +**Author(s):** *Kelly M. Hoffman, Sophie Trawalter, Jordan R. Axta, M. Norman Oliver*
1212 +**Title:** *"Racial Bias in Pain Assessment and Treatment Recommendations, and False Beliefs About Biological Differences Between Blacks and Whites"*
1213 +**DOI:** [10.1073/pnas.1516047113](https://doi.org/10.1073/pnas.1516047113)
1214 +**Subject Matter:** *Health Disparities, Racial Bias, Medical Treatment*
1215 +
1216 +---
1217 +
1218 +## **Key Statistics**
1219 +1. **General Observations:**
1220 + - Study analyzed **racial disparities in pain perception and treatment recommendations**.
1221 + - Found that **white laypeople and medical students endorsed false beliefs about biological differences** between Black and white individuals.
1222 +
1223 +2. **Subgroup Analysis:**
1224 + - **50% of medical students surveyed endorsed at least one false belief about biological differences**.
1225 + - Participants who held these false beliefs were **more likely to underestimate Black patients’ pain levels**.
1226 +
1227 +3. **Other Significant Data Points:**
1228 + - **Black patients were less likely to receive appropriate pain treatment** compared to white patients.
1229 + - The study confirmed that **historical misconceptions about racial differences still persist in modern medicine**.
1230 +
1231 +---
1232 +
1233 +## **Findings**
1234 +1. **Primary Observations:**
1235 + - False beliefs about biological racial differences **correlate with racial disparities in pain treatment**.
1236 + - Medical students and residents who endorsed these beliefs **showed greater racial bias in treatment recommendations**.
1237 +
1238 +2. **Subgroup Trends:**
1239 + - Physicians who **did not endorse these beliefs** showed **no racial bias** in treatment recommendations.
1240 + - Bias was **strongest among first-year medical students** and decreased slightly in later years of training.
1241 +
1242 +3. **Specific Case Analysis:**
1243 + - Study participants **underestimated Black patients' pain and recommended less effective pain treatments**.
1244 + - The study suggests that **racial disparities in medical care stem, in part, from these enduring false beliefs**.
1245 +
1246 +---
1247 +
1248 +## **Critique and Observations**
1249 +1. **Strengths of the Study:**
1250 + - **First empirical study to connect false racial beliefs with medical decision-making**.
1251 + - Utilizes a **large sample of medical students and residents** from diverse institutions.
1252 +
1253 +2. **Limitations of the Study:**
1254 + - The study focuses on **Black vs. white disparities**, leaving other racial/ethnic groups unexplored.
1255 + - Participants' responses were based on **hypothetical medical cases, not real-world treatment decisions**.
1256 +
1257 +3. **Suggestions for Improvement:**
1258 + - Future research should examine **how these biases manifest in real clinical settings**.
1259 + - Investigate **whether medical training can correct these biases over time**.
1260 +
1261 +---
1262 +
1263 +## **Relevance to Subproject**
1264 +- Highlights **racial disparities in healthcare**, specifically in pain assessment and treatment.
1265 +- Supports **research on implicit bias and its impact on medical outcomes**.
1266 +- Provides evidence for **the need to address racial bias in medical education**.
1267 +
1268 +---
1269 +
1270 +## **Suggestions for Further Exploration**
1271 +1. Investigate **interventions to reduce racial bias in medical decision-making**.
1272 +2. Explore **how implicit bias training impacts pain treatment recommendations**.
1273 +3. Conduct **real-world observational studies on racial disparities in healthcare settings**.
1274 +
1275 +---
1276 +
1277 +## **Summary of Research Study**
1278 +This study examines **racial bias in pain perception and treatment** among **white laypeople and medical professionals**, demonstrating that **false beliefs about biological differences contribute to disparities in pain management**. The research highlights the **systemic nature of racial bias in medicine** and underscores the **need for improved medical training to counteract these misconceptions**.
1279 +
1280 +This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1281 +
1282 +---
1283 +
1284 +## **📄 Download Full Study**
1285 +[[Download Full Study>>attach:10.1073_pnas.1516047113.pdf]]
1286 +
1287 +{{/expand}}
1288 +
1289 +{{html}}<hr style="border: 3px solid red;">{{/html}}
1290 +
1291 +
1292 +{{expand title="Study: Rising Morbidity and Mortality in Midlife Among White Non-Hispanic Americans" expanded="false"}}
1293 +**Source:** *Proceedings of the National Academy of Sciences (PNAS)*
1294 +**Date of Publication:** *2015*
1295 +**Author(s):** *Anne Case, Angus Deaton*
1296 +**Title:** *"Rising Morbidity and Mortality in Midlife Among White Non-Hispanic Americans in the 21st Century"*
1297 +**DOI:** [10.1073/pnas.1518393112](https://doi.org/10.1073/pnas.1518393112)
1298 +**Subject Matter:** *Public Health, Mortality, Socioeconomic Factors*
1299 +
1300 +---
1301 +
1302 +## **Key Statistics**
1303 +1. **General Observations:**
1304 + - Mortality rates among **middle-aged white non-Hispanic Americans (ages 45–54)** increased from 1999 to 2013.
1305 + - This reversal in mortality trends is unique to the U.S.; **no other wealthy country experienced a similar rise**.
1306 +
1307 +2. **Subgroup Analysis:**
1308 + - The increase was **most pronounced among those with a high school education or less**.
1309 + - Hispanic and Black non-Hispanic mortality continued to decline over the same period.
1310 +
1311 +3. **Other Significant Data Points:**
1312 + - Rising mortality was driven primarily by **suicide, drug and alcohol poisoning, and chronic liver disease**.
1313 + - Midlife morbidity increased as well, with more reports of **poor health, pain, and mental distress**.
1314 +
1315 +---
1316 +
1317 +## **Findings**
1318 +1. **Primary Observations:**
1319 + - The rise in mortality is attributed to **substance abuse, economic distress, and deteriorating mental health**.
1320 + - The increase in **suicides and opioid overdoses parallels broader socioeconomic decline**.
1321 +
1322 +2. **Subgroup Trends:**
1323 + - The **largest mortality increases** occurred among **whites without a college degree**.
1324 + - Chronic pain, functional limitations, and self-reported mental distress **rose significantly in affected groups**.
1325 +
1326 +3. **Specific Case Analysis:**
1327 + - **Educational attainment was a major predictor of mortality trends**, with better-educated individuals experiencing lower mortality rates.
1328 + - Mortality among **white Americans with a college degree continued to decline**, resembling trends in other wealthy nations.
1329 +
1330 +---
1331 +
1332 +## **Critique and Observations**
1333 +1. **Strengths of the Study:**
1334 + - **First major study to highlight rising midlife mortality among U.S. whites**.
1335 + - Uses **CDC and Census mortality data spanning over a decade**.
1336 +
1337 +2. **Limitations of the Study:**
1338 + - Does not establish **causality** between economic decline and increased mortality.
1339 + - Lacks **granular data on opioid prescribing patterns and regional differences**.
1340 +
1341 +3. **Suggestions for Improvement:**
1342 + - Future studies should explore **how economic shifts, healthcare access, and mental health treatment contribute to these trends**.
1343 + - Further research on **racial and socioeconomic disparities in mortality trends** is needed.
1344 +
1345 +---
1346 +
1347 +## **Relevance to Subproject**
1348 +- Highlights **socioeconomic and racial disparities** in health outcomes.
1349 +- Supports research on **substance abuse and mental health crises in the U.S.**.
1350 +- Provides evidence for **the role of economic instability in public health trends**.
1351 +
1352 +---
1353 +
1354 +## **Suggestions for Further Exploration**
1355 +1. Investigate **regional differences in rising midlife mortality**.
1356 +2. Examine the **impact of the opioid crisis on long-term health trends**.
1357 +3. Study **policy interventions aimed at reversing rising mortality rates**.
1358 +
1359 +---
1360 +
1361 +## **Summary of Research Study**
1362 +This study documents a **reversal in mortality trends among middle-aged white non-Hispanic Americans**, showing an increase in **suicide, drug overdoses, and alcohol-related deaths** from 1999 to 2013. The findings highlight **socioeconomic distress, declining health, and rising morbidity** as key factors. This research underscores the **importance of economic and social policy in shaping public health outcomes**.
1363 +
1364 +This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1365 +
1366 +---
1367 +
1368 +## **📄 Download Full Study**
1369 +[[Download Full Study>>attach:10.1073_pnas.1518393112.pdf]]
1370 +
1371 +{{/expand}}
1372 +
1373 +{{html}}<hr style="border: 3px solid red;">{{/html}}
1374 +
1375 +{{expand title="Study: How Do People Without Migration Background Experience and Impact Today’s Superdiverse Cities?" expanded="false"}}
1376 +**Source:** *Journal of Ethnic and Migration Studies*
1377 +**Date of Publication:** *2023*
1378 +**Author(s):** *Maurice Crul, Frans Lelie, Elif Keskiner, Laure Michon, Ismintha Waldring*
1379 +**Title:** *"How Do People Without Migration Background Experience and Impact Today’s Superdiverse Cities?"*
1380 +**DOI:** [10.1080/1369183X.2023.2182548](https://doi.org/10.1080/1369183X.2023.2182548)
1381 +**Subject Matter:** *Urban Sociology, Migration Studies, Integration*
1382 +
1383 +---
1384 +
1385 +## **Key Statistics**
1386 +1. **General Observations:**
1387 + - Study examines the role of **people without migration background** in majority-minority cities.
1388 + - Analyzes **over 3,000 survey responses and 150 in-depth interviews** from six North-Western European cities.
1389 +
1390 +2. **Subgroup Analysis:**
1391 + - Explores differences in **integration, social interactions, and perceptions of diversity**.
1392 + - Studies how **class, education, and neighborhood composition** affect adaptation to urban diversity.
1393 +
1394 +3. **Other Significant Data Points:**
1395 + - The study introduces the **Becoming a Minority (BaM) project**, a large-scale investigation of urban demographic shifts.
1396 + - **People without migration background perceive diversity differently**, with some embracing and others resisting change.
1397 +
1398 +---
1399 +
1400 +## **Findings**
1401 +1. **Primary Observations:**
1402 + - The study **challenges traditional integration theories**, arguing that non-migrant groups also undergo adaptation processes.
1403 + - Some residents **struggle with demographic changes**, while others see diversity as an asset.
1404 +
1405 +2. **Subgroup Trends:**
1406 + - Young, educated individuals in urban areas **are more open to cultural diversity**.
1407 + - Older and less mobile residents **report feelings of displacement and social isolation**.
1408 +
1409 +3. **Specific Case Analysis:**
1410 + - Examines how **people without migration background navigate majority-minority settings** in cities like Amsterdam and Vienna.
1411 + - Analyzes **whether former ethnic majority groups now perceive themselves as minorities**.
1412 +
1413 +---
1414 +
1415 +## **Critique and Observations**
1416 +1. **Strengths of the Study:**
1417 + - **Innovative approach** by examining the impact of migration on native populations.
1418 + - Uses **both qualitative and quantitative data** for robust analysis.
1419 +
1420 +2. **Limitations of the Study:**
1421 + - Limited to **Western European urban settings**, missing perspectives from other global regions.
1422 + - Does not fully explore **policy interventions for fostering social cohesion**.
1423 +
1424 +3. **Suggestions for Improvement:**
1425 + - Expand research to **other geographical contexts** to understand migration effects globally.
1426 + - Investigate **long-term trends in urban adaptation and community building**.
1427 +
1428 +---
1429 +
1430 +## **Relevance to Subproject**
1431 +- Provides a **new perspective on urban integration**, shifting focus from migrants to native-born populations.
1432 +- Highlights the **role of social and economic power in shaping urban diversity outcomes**.
1433 +- Challenges existing **assimilation theories by showing bidirectional adaptation in diverse cities**.
1434 +
1435 +---
1436 +
1437 +## **Suggestions for Further Exploration**
1438 +1. Study how **local policies shape attitudes toward urban diversity**.
1439 +2. Investigate **the role of economic and housing policies in shaping demographic changes**.
1440 +3. Explore **how social networks influence perceptions of migration and diversity**.
1441 +
1442 +---
1443 +
1444 +## **Summary of Research Study**
1445 +This study examines how **people without migration background experience demographic change in majority-minority cities**. Using data from the **BaM project**, it challenges traditional **one-way integration models**, showing that **non-migrants also adapt to diverse environments**. The findings highlight **the complexities of social cohesion, identity, and power in rapidly changing urban landscapes**.
1446 +
1447 +This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1448 +
1449 +---
1450 +
1451 +## **📄 Download Full Study**
1452 +[[Download Full Study>>attach:10.1080_1369183X.2023.2182548.pdf]]
1453 +
1454 +{{/expand}}
1455 +
1456 +{{html}}<hr style="border: 3px solid red;">{{/html}}
1457 +
1458 +{{expand title="Study: Factors Associated with Completion of a Drug Treatment Court Diversion Program" expanded="false"}}
1459 +**Source:** *Substance Use & Misuse*
1208 1208  **Date of Publication:** *2002*
1209 -**Author(s):** *Sarah A. Tishkoff, Scott M. Williams*
1210 -**Title:** *"Genetic Analysis of African Populations: Human Evolution and Complex Disease"*
1211 -**DOI:** [10.1038/nrg865](https://doi.org/10.1038/nrg865)
1212 -**Subject Matter:** *Population Genetics, Human Evolution, Complex Diseases*
1461 +**Author(s):** *Clifford A. Butzin, Christine A. Saum, Frank R. Scarpitti*
1462 +**Title:** *"Factors Associated with Completion of a Drug Treatment Court Diversion Program"*
1463 +**DOI:** [10.1081/JA-120014424](https://doi.org/10.1081/JA-120014424)
1464 +**Subject Matter:** *Substance Use, Criminal Justice, Drug Courts*
1213 1213  
1214 1214  ---
1215 1215  
1216 1216  ## **Key Statistics**
1217 1217  1. **General Observations:**
1218 - - Africa harbors **the highest genetic diversity** of any region, making it key to understanding human evolution.
1219 - - The study analyzes **genetic variation and linkage disequilibrium (LD) in African populations**.
1470 + - Study examined **drug treatment court success rates** among first-time offenders.
1471 + - Strongest predictors of **successful completion were employment status and race**.
1220 1220  
1221 1221  2. **Subgroup Analysis:**
1222 - - African populations exhibit **greater genetic differentiation compared to non-Africans**.
1223 - - **Migration and admixture** have shaped modern African genomes over the past **100,000 years**.
1474 + - Individuals with **stable jobs were more likely to complete the program**.
1475 + - **Black participants had lower success rates**, suggesting potential systemic disparities.
1224 1224  
1225 1225  3. **Other Significant Data Points:**
1226 - - The **effective population size (Ne) of Africans** is higher than that of non-African populations.
1227 - - LD blocks are **shorter in African genomes**, suggesting more historical recombination events.
1478 + - **Education level was positively correlated** with program completion.
1479 + - Frequency of **drug use before enrollment affected treatment outcomes**.
1228 1228  
1229 1229  ---
1230 1230  
1231 1231  ## **Findings**
1232 1232  1. **Primary Observations:**
1233 - - African populations are the **most genetically diverse**, supporting the *Recent African Origin* hypothesis.
1234 - - Genetic variation in African populations can **help fine-map complex disease genes**.
1485 + - **Social stability factors** (employment, education) were key to treatment success.
1486 + - **Race and pre-existing substance use patterns** influenced completion rates.
1235 1235  
1236 1236  2. **Subgroup Trends:**
1237 - - **West Africans exhibit higher genetic diversity** than East Africans due to differing migration patterns.
1238 - - Populations such as **San hunter-gatherers show deep genetic divergence**.
1489 + - White offenders had **higher completion rates** than Black offenders.
1490 + - Drug court success was **higher for those with lower initial drug use frequency**.
1239 1239  
1240 1240  3. **Specific Case Analysis:**
1241 - - Admixture in African Americans includes **West African and European genetic contributions**.
1242 - - SNP (single nucleotide polymorphism) diversity in African genomes **exceeds that of non-African groups**.
1493 + - **Individuals with strong social ties were more likely to finish the program**.
1494 + - Success rates were **significantly higher for participants with case management support**.
1243 1243  
1244 1244  ---
1245 1245  
1246 1246  ## **Critique and Observations**
1247 1247  1. **Strengths of the Study:**
1248 - - Provides **comprehensive genetic analysis** of diverse African populations.
1249 - - Highlights **how genetic diversity impacts health disparities and disease risks**.
1500 + - **First empirical study on drug court program success factors**.
1501 + - Uses **longitudinal data** for post-treatment analysis.
1250 1250  
1251 1251  2. **Limitations of the Study:**
1252 - - Many **African populations remain understudied**, limiting full understanding of diversity.
1253 - - Focuses more on genetic variation than on **specific disease mechanisms**.
1504 + - Lacks **qualitative data on personal motivation and treatment engagement**.
1505 + - Focuses on **short-term program success** without tracking **long-term relapse rates**.
1254 1254  
1255 1255  3. **Suggestions for Improvement:**
1256 - - Expand research into **underrepresented African populations**.
1257 - - Integrate **whole-genome sequencing for a more detailed evolutionary timeline**.
1508 + - Future research should examine **racial disparities in drug court outcomes**.
1509 + - Study **how community resources impact long-term recovery**.
1258 1258  
1259 1259  ---
1260 1260  
1261 1261  ## **Relevance to Subproject**
1262 -- Supports **genetic models of human evolution** and the **out-of-Africa hypothesis**.
1263 -- Reinforces **Africa’s key role in disease gene mapping and precision medicine**.
1264 -- Provides insight into **historical migration patterns and their genetic impact**.
1514 +- Provides insight into **what factors contribute to drug court program success**.
1515 +- Highlights **racial disparities in criminal justice-based rehabilitation programs**.
1516 +- Supports **policy discussions on improving access to drug treatment for marginalized groups**.
1265 1265  
1266 1266  ---
1267 1267  
1268 1268  ## **Suggestions for Further Exploration**
1269 -1. Investigate **genetic adaptations to local environments within Africa**.
1270 -2. Study **the role of African genetic diversity in disease resistance**.
1271 -3. Expand research on **how ancient migration patterns shaped modern genetic structure**.
1521 +1. Investigate **the role of mental health in drug court success rates**.
1522 +2. Assess **long-term relapse prevention strategies post-treatment**.
1523 +3. Explore **alternative diversion programs beyond traditional drug courts**.
1272 1272  
1273 1273  ---
1274 1274  
1275 1275  ## **Summary of Research Study**
1276 -This study explores the **genetic diversity of African populations**, analyzing their role in **human evolution and complex disease research**. The findings highlight **Africa’s unique genetic landscape**, confirming it as the most genetically diverse continent. The research provides valuable insights into **how genetic variation influences disease susceptibility, evolution, and population structure**.
1528 +This study examines **factors influencing the completion of drug treatment court programs**, identifying **employment, education, and race as key predictors**. The research underscores **systemic disparities in drug court outcomes**, emphasizing the need for **improved support systems for at-risk populations**.
1277 1277  
1278 1278  This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1279 1279  
... ... @@ -1280,7 +1280,7 @@
1280 1280  ---
1281 1281  
1282 1282  ## **📄 Download Full Study**
1283 -[[Download Full Study>>attach:10.1038_nrg865MODERN.pdf]]
1535 +[[Download Full Study>>attach:10.1081_JA-120014424.pdf]]
1284 1284  
1285 1285  {{/expand}}
1286 1286  
... ... @@ -1287,4 +1287,252 @@
1287 1287  {{html}}<hr style="border: 3px solid red;">{{/html}}
1288 1288  
1289 1289  
1542 +{{expand title="Study: Cross-Cultural Sources of Measurement Error in Substance Use Surveys" expanded="false"}}
1543 +**Source:** *Substance Use & Misuse*
1544 +**Date of Publication:** *2003*
1545 +**Author(s):** *Timothy P. Johnson, Phillip J. Bowman*
1546 +**Title:** *"Cross-Cultural Sources of Measurement Error in Substance Use Surveys"*
1547 +**DOI:** [10.1081/JA-120023394](https://doi.org/10.1081/JA-120023394)
1548 +**Subject Matter:** *Survey Methodology, Racial Disparities, Substance Use Research*
1290 1290  
1550 +---
1551 +
1552 +## **Key Statistics**
1553 +1. **General Observations:**
1554 + - Study examined **how racial and cultural factors influence self-reported substance use data**.
1555 + - Analyzed **36 empirical studies from 1977–2003** on survey reliability across racial/ethnic groups.
1556 +
1557 +2. **Subgroup Analysis:**
1558 + - Black and Latino respondents **were more likely to underreport drug use** compared to White respondents.
1559 + - **Cultural stigma and distrust in research institutions** affected self-report accuracy.
1560 +
1561 +3. **Other Significant Data Points:**
1562 + - **Surveys using biological validation (urinalysis, hair tests) revealed underreporting trends**.
1563 + - **Higher recantation rates** (denying past drug use) were observed among minority respondents.
1564 +
1565 +---
1566 +
1567 +## **Findings**
1568 +1. **Primary Observations:**
1569 + - Racial/ethnic disparities in **substance use reporting bias survey-based research**.
1570 + - **Social desirability and cultural norms impact data reliability**.
1571 +
1572 +2. **Subgroup Trends:**
1573 + - White respondents were **more likely to overreport** substance use.
1574 + - Black and Latino respondents **had higher recantation rates**, particularly in face-to-face interviews.
1575 +
1576 +3. **Specific Case Analysis:**
1577 + - Mode of survey administration **significantly influenced reporting accuracy**.
1578 + - **Self-administered surveys produced more reliable data than interviewer-administered surveys**.
1579 +
1580 +---
1581 +
1582 +## **Critique and Observations**
1583 +1. **Strengths of the Study:**
1584 + - **Comprehensive review of 36 studies** on measurement error in substance use reporting.
1585 + - Identifies **systemic biases affecting racial/ethnic survey reliability**.
1586 +
1587 +2. **Limitations of the Study:**
1588 + - Relies on **secondary data analysis**, limiting direct experimental control.
1589 + - Does not explore **how measurement error impacts policy decisions**.
1590 +
1591 +3. **Suggestions for Improvement:**
1592 + - Future research should **incorporate mixed-method approaches** (qualitative & quantitative).
1593 + - Investigate **how survey design can reduce racial reporting disparities**.
1594 +
1595 +---
1596 +
1597 +## **Relevance to Subproject**
1598 +- Supports research on **racial disparities in self-reported health behaviors**.
1599 +- Highlights **survey methodology issues that impact substance use epidemiology**.
1600 +- Provides insights for **improving data accuracy in public health research**.
1601 +
1602 +---
1603 +
1604 +## **Suggestions for Further Exploration**
1605 +1. Investigate **how survey design impacts racial disparities in self-reported health data**.
1606 +2. Study **alternative data collection methods (biometric validation, passive data tracking)**.
1607 +3. Explore **the role of social stigma in self-reported health behaviors**.
1608 +
1609 +---
1610 +
1611 +## **Summary of Research Study**
1612 +This study examines **cross-cultural biases in self-reported substance use surveys**, showing that **racial/ethnic minorities are more likely to underreport drug use** due to **social stigma, research distrust, and survey administration methods**. The findings highlight **critical issues in public health data collection and the need for improved survey design**.
1613 +
1614 +This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1615 +
1616 +---
1617 +
1618 +## **📄 Download Full Study**
1619 +[[Download Full Study>>attach:10.1081_JA-120023394.pdf]]
1620 +
1621 +{{/expand}}
1622 +
1623 +{{html}}<hr style="border: 3px solid red;">{{/html}}
1624 +
1625 +{{expand title="Study: Cross-Cultural Sources of Measurement Error in Substance Use Surveys" expanded="false"}}
1626 +**Source:** *Substance Use & Misuse*
1627 +**Date of Publication:** *2003*
1628 +**Author(s):** *Timothy P. Johnson, Phillip J. Bowman*
1629 +**Title:** *"Cross-Cultural Sources of Measurement Error in Substance Use Surveys"*
1630 +**DOI:** [10.1081/JA-120023394](https://doi.org/10.1081/JA-120023394)
1631 +**Subject Matter:** *Survey Methodology, Racial Disparities, Substance Use Research*
1632 +
1633 +---
1634 +
1635 +## **Key Statistics**
1636 +1. **General Observations:**
1637 + - Study examined **how racial and cultural factors influence self-reported substance use data**.
1638 + - Analyzed **36 empirical studies from 1977–2003** on survey reliability across racial/ethnic groups.
1639 +
1640 +2. **Subgroup Analysis:**
1641 + - Black and Latino respondents **were more likely to underreport drug use** compared to White respondents.
1642 + - **Cultural stigma and distrust in research institutions** affected self-report accuracy.
1643 +
1644 +3. **Other Significant Data Points:**
1645 + - **Surveys using biological validation (urinalysis, hair tests) revealed underreporting trends**.
1646 + - **Higher recantation rates** (denying past drug use) were observed among minority respondents.
1647 +
1648 +---
1649 +
1650 +## **Findings**
1651 +1. **Primary Observations:**
1652 + - Racial/ethnic disparities in **substance use reporting bias survey-based research**.
1653 + - **Social desirability and cultural norms impact data reliability**.
1654 +
1655 +2. **Subgroup Trends:**
1656 + - White respondents were **more likely to overreport** substance use.
1657 + - Black and Latino respondents **had higher recantation rates**, particularly in face-to-face interviews.
1658 +
1659 +3. **Specific Case Analysis:**
1660 + - Mode of survey administration **significantly influenced reporting accuracy**.
1661 + - **Self-administered surveys produced more reliable data than interviewer-administered surveys**.
1662 +
1663 +---
1664 +
1665 +## **Critique and Observations**
1666 +1. **Strengths of the Study:**
1667 + - **Comprehensive review of 36 studies** on measurement error in substance use reporting.
1668 + - Identifies **systemic biases affecting racial/ethnic survey reliability**.
1669 +
1670 +2. **Limitations of the Study:**
1671 + - Relies on **secondary data analysis**, limiting direct experimental control.
1672 + - Does not explore **how measurement error impacts policy decisions**.
1673 +
1674 +3. **Suggestions for Improvement:**
1675 + - Future research should **incorporate mixed-method approaches** (qualitative & quantitative).
1676 + - Investigate **how survey design can reduce racial reporting disparities**.
1677 +
1678 +---
1679 +
1680 +## **Relevance to Subproject**
1681 +- Supports research on **racial disparities in self-reported health behaviors**.
1682 +- Highlights **survey methodology issues that impact substance use epidemiology**.
1683 +- Provides insights for **improving data accuracy in public health research**.
1684 +
1685 +---
1686 +
1687 +## **Suggestions for Further Exploration**
1688 +1. Investigate **how survey design impacts racial disparities in self-reported health data**.
1689 +2. Study **alternative data collection methods (biometric validation, passive data tracking)**.
1690 +3. Explore **the role of social stigma in self-reported health behaviors**.
1691 +
1692 +---
1693 +
1694 +## **Summary of Research Study**
1695 +This study examines **cross-cultural biases in self-reported substance use surveys**, showing that **racial/ethnic minorities are more likely to underreport drug use** due to **social stigma, research distrust, and survey administration methods**. The findings highlight **critical issues in public health data collection and the need for improved survey design**.
1696 +
1697 +This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1698 +
1699 +---
1700 +
1701 +## **📄 Download Full Study**
1702 +[[Download Full Study>>attach:10.1081_JA-120023394.pdf]]
1703 +
1704 +{{/expand}}
1705 +
1706 +{{html}}<hr style="border: 3px solid red;">{{/html}}
1707 +
1708 +{{expand title="Study: Factors Associated with Completion of a Drug Treatment Court Diversion Program" expanded="false"}}
1709 +**Source:** *Substance Use & Misuse*
1710 +**Date of Publication:** *2002*
1711 +**Author(s):** *Clifford A. Butzin, Christine A. Saum, Frank R. Scarpitti*
1712 +**Title:** *"Factors Associated with Completion of a Drug Treatment Court Diversion Program"*
1713 +**DOI:** [10.1081/JA-120014424](https://doi.org/10.1081/JA-120014424)
1714 +**Subject Matter:** *Substance Use, Criminal Justice, Drug Courts*
1715 +
1716 +---
1717 +
1718 +## **Key Statistics**
1719 +1. **General Observations:**
1720 + - Study examined **drug treatment court success rates** among first-time offenders.
1721 + - Strongest predictors of **successful completion were employment status and race**.
1722 +
1723 +2. **Subgroup Analysis:**
1724 + - Individuals with **stable jobs were more likely to complete the program**.
1725 + - **Black participants had lower success rates**, suggesting potential systemic disparities.
1726 +
1727 +3. **Other Significant Data Points:**
1728 + - **Education level was positively correlated** with program completion.
1729 + - Frequency of **drug use before enrollment affected treatment outcomes**.
1730 +
1731 +---
1732 +
1733 +## **Findings**
1734 +1. **Primary Observations:**
1735 + - **Social stability factors** (employment, education) were key to treatment success.
1736 + - **Race and pre-existing substance use patterns** influenced completion rates.
1737 +
1738 +2. **Subgroup Trends:**
1739 + - White offenders had **higher completion rates** than Black offenders.
1740 + - Drug court success was **higher for those with lower initial drug use frequency**.
1741 +
1742 +3. **Specific Case Analysis:**
1743 + - **Individuals with strong social ties were more likely to finish the program**.
1744 + - Success rates were **significantly higher for participants with case management support**.
1745 +
1746 +---
1747 +
1748 +## **Critique and Observations**
1749 +1. **Strengths of the Study:**
1750 + - **First empirical study on drug court program success factors**.
1751 + - Uses **longitudinal data** for post-treatment analysis.
1752 +
1753 +2. **Limitations of the Study:**
1754 + - Lacks **qualitative data on personal motivation and treatment engagement**.
1755 + - Focuses on **short-term program success** without tracking **long-term relapse rates**.
1756 +
1757 +3. **Suggestions for Improvement:**
1758 + - Future research should examine **racial disparities in drug court outcomes**.
1759 + - Study **how community resources impact long-term recovery**.
1760 +
1761 +---
1762 +
1763 +## **Relevance to Subproject**
1764 +- Provides insight into **what factors contribute to drug court program success**.
1765 +- Highlights **racial disparities in criminal justice-based rehabilitation programs**.
1766 +- Supports **policy discussions on improving access to drug treatment for marginalized groups**.
1767 +
1768 +---
1769 +
1770 +## **Suggestions for Further Exploration**
1771 +1. Investigate **the role of mental health in drug court success rates**.
1772 +2. Assess **long-term relapse prevention strategies post-treatment**.
1773 +3. Explore **alternative diversion programs beyond traditional drug courts**.
1774 +
1775 +---
1776 +
1777 +## **Summary of Research Study**
1778 +This study examines **factors influencing the completion of drug treatment court programs**, identifying **employment, education, and race as key predictors**. The research underscores **systemic disparities in drug court outcomes**, emphasizing the need for **improved support systems for at-risk populations**.
1779 +
1780 +This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1781 +
1782 +---
1783 +
1784 +## **📄 Download Full Study**
1785 +[[Download Full Study>>attach:10.1081_JA-120014424.pdf]]
1786 +
1787 +{{/expand}}
1788 +
1789 +{{html}}<hr style="border: 3px solid red;">{{/html}}
1790 +